8 min read
Monthly FDA Guidance and Regulatory News Review - July 2026
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
1 min read
Meet Veristat at booth #1713 at the upcoming DIA Annual Meeting.
DIA Annual Meeting | June 24-27, 2019 | San Diego, CA
We provide impactful strategies and solutions to meet your outsourcing needs in order to plan and run your next clinical trial, program or regulatory submission project. Our 25 years of experience helping emerging and small to mid-size biotech firms take their products from IND to NDA approval are worth taking a look at. In 2018 alone, our team prepared the regulatory submissions for 12% of the NMEs approved by the FDA. And, many of those programs we supported since the writing of the study protocols and IND.
Apply our strategic approaches and tactical solutions to help you:
- Develop your IND or support your programming planning
- Recruit patients quickly to get your early phase trials up and running
- Collect and clean your clinical trial data
- Convert and analyze your data in preparation of your marketing applications
- Write your clinical study reports and submission document modules
- Assist with your regulatory submissions and agency meetings
We provide our impactful solutions on both a full-service or functional service basis. Speak with us at the DIA Annual Meeting to learn more.
Schedule A Meeting
Schedule a meeting by filling out the form on the right. Find out how we can help you advance your next clinical trial or regulatory submission to successful outcomes. Or, read some of our recent insightful perspectives.
Explore our Key Related Areas: